首页> 外文学位 >Development and characterization of double walled microspheres from poly(L-lactide) and poly(D,L-lactide-co-glycolide) blends.
【24h】

Development and characterization of double walled microspheres from poly(L-lactide) and poly(D,L-lactide-co-glycolide) blends.

机译:由聚(L-丙交酯)和聚(D,L-丙交酯-共-乙交酯)共混物制备双壁微球并进行表征。

获取原文
获取原文并翻译 | 示例

摘要

Double walled microspheres were developed from biodegradable polymers, poly(l-lactide), PLLA and poly(d,l-lactide-co-glycolide), PLGA, by the solvent evaporation microencapsulation process. PLLA and PLGA are the polymers of choice in drug delivery due to their versatility in terms of degradation that can be varied depending on their molecular weight and monomer ratios. The binary blend of PLLA and PLGA in methylene chloride phase separates to form double walled microspheres with an outer layer rich in PLLA and the inner core predominantly rich in PLGA. The PLLA PLGA phase separation behavior has been well characterized using a ternary phase diagram and the orientation of the phases within an aqueous environment has been illustrated using Harkin's equations for emulsion theory. Two model agents, fluorescent labeled bovine serum albumin, FITC-BSA, representing a hydrophilic agent and iron oxide representing a hydrophobic agent, were localized in either one of the two layers. Manipulating the relative polymer ratio at constant overall polymer concentration and the polymer in which the agent is introduced during the pre-encapsulation steps allowed for control of the localization. Double walled microspheres with the protein localized in the inner core had several advantages in that it reduced burst effects associated with protein encapsulated near the surface of the microspheres where the outer layer acted as a modulator and controlled the release of the protein.; Probe sonication of the first emulsion was shown to increase encapsulation efficiency of FITC-BSA whereas the polymer ratio of 1:3 was shown to localize the FITC-BSA in the inner core. Therefore these steps were incorporated into the technique. In vitro degradation of these spheres can be broken down into two phases, the first phase lasting for 40 days representing mostly the PLGA degradation after which the microsphere structure collapses and a much slower second phase mostly represented by the PLLA degradation.; Sustained delivery of insulin indicted Type I diabetes and olanzapine indicated for schizophrenia was shown in diabetic and normal rats respectively using double walled spheres. Double walled spheres made form PLLA and PLGA show great promise as a drug delivery platform for several applications that require sustained delivery.
机译:通过溶剂蒸发微囊化工艺,从可生物降解的聚合物聚(丙交酯),聚乳酸(PLLA)和聚(丙交酯-乙交酯-乙交酯)共聚物开发了双壁微球。 PLLA和PLGA是药物递送中的首选聚合物,因为它们在降解方面的多功能性可以根据其分子量和单体比率而变化。 PLLA和PLGA在二氯甲烷相中的二元共混物分离形成双壁微球,其外层富含PLLA,内芯主要富含PLGA。使用三元相图可以很好地表征PLLA PLGA相分离行为,并且可以使用乳液理论的Harkin方程来说明水性环境中的相取向。两种模型剂,荧光标记的牛血清白蛋白,代表亲水剂的FITC-BSA和代表疏水剂的氧化铁,位于两层的任一层中。在恒定的总聚合物浓度下操作相对聚合物比例,以及在预封装步骤中将试剂引入其中的聚合物,可以控制定位。具有位于内部核心中的蛋白质的双壁微球具有几个优点,因为它减少了与包裹在微球表面附近的蛋白质相关的爆发效应,其中外层充当调节剂并控制蛋白质的释放。第一乳液的探针超声处理显示出提高了FITC-BSA的封装效率,而聚合物比率为1:3则表明FITC-BSA位于内核中。因此,这些步骤被合并到该技术中。这些球的体外降解可分为两个阶段,第一阶段持续40天,主要代表PLGA降解,此后微球结构崩溃,第二阶段缓慢得多,主要表现为PLLA降解。使用双壁球体分别在糖尿病大鼠和正常大鼠中显示了胰岛素指示的I型糖尿病的持续递送和指示用于精神分裂症的奥氮平。由PLLA和PLGA制成的双壁球体作为药物输送平台具有广阔的前景,可用于需要持续输送的多种应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号